Kevin A. Buhr

TL;DR: Although there was evidence of an off-target effect of torcetrapib, it cannot rule out adverse effects related to CETP inhibition, and the trial was terminated prematurely because of an increased risk of death and cardiac events.

TL;DR: This RCT demonstrates that a competency-based research mentor training program can improve mentors’ skills.

TL;DR: Among patients with recent acute coronary syndrome, type 2 diabetes, and low high-density lipoprotein cholesterol levels, the selective bromodomain and extraterminal protein inhibitor apabetalone added to standard therapy did not significantly reduce the risk of major adverse cardiovascular events.

TL;DR: A machine learning algorithm produced a model that predicted clinical outcomes after CRT that may better differentiate outcomes over current clinical discriminators and improve shared decision-making with patients.

TL;DR: The findings support the hypothesis that residual symptom burden is related to post-cancer employment: Residual symptoms may be targets for intervention to improve work outcomes among cancer survivors.